Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EGFR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05378360
What this trial is testing

DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities

Who this might be right for
Rash Acneiform
Daewoong Pharmaceutical Co. LTD. 96
Testing effectiveness (Phase 2)Study completedNCT02187991
What this trial is testing

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaBreast Tumors+1 more
US Oncology Research 169
Testing effectiveness (Phase 2)UnknownNCT05332574
What this trial is testing

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Who this might be right for
NSCLCOther Solid Tumors
Genor Biopharma Co., Ltd. 120
Early research (Phase 1)Ended earlyNCT03891615
What this trial is testing

Niraparib in Combination With Osimertinib in EGFR-Mutated Advanced Lung Cancer

Who this might be right for
Lung Cancer
Massachusetts General Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03269526
What this trial is testing

BATs Treatment for Pancreatic Cancer, Phase Ib/II

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic Adenocarcinoma
University of Virginia 22
Early research (Phase 1)Study completedNCT03463525
What this trial is testing

Open-label PET Study With [11C]Osimertinib in Patients With EGFRm NSCLC and Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 4
Early research (Phase 1)Ended earlyNCT03682497
What this trial is testing

Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium

Who this might be right for
Heart Failure
AstraZeneca 68
Not applicableUnknownNCT04116918
What this trial is testing

Efficacy and Safety of the Combination of Anlotinib and JS001 in EGFR-TKI Resistant T790M-Negative NSCLC

Who this might be right for
NSCLC Stage IVEGFR T790M-negativeAnlotinib+1 more
Baodong Qin 100
Testing effectiveness (Phase 2)UnknownNCT02873390
What this trial is testing

PD-1 Antibody Expressing CAR-T Cells for EGFR Family Member Positive Advanced Solid Tumor

Who this might be right for
PD-1 AntibodyCAR-T CellsAdvanced Malignancies
Ningbo Cancer Hospital 20
Not applicableUnknownNCT04768491
What this trial is testing

Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC

Who this might be right for
EGFR Activating MutationNSCLC Stage IVNSCLC Stage IIIB+1 more
Peking Union Medical College 82
Large-scale testing (Phase 3)Looking for participantsNCT05852990
What this trial is testing

Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC

Who this might be right for
Non-Small Cell Lung Cancer With EGFR Mutation
Instituto Nacional de Cancerologia de Mexico 28
Early research (Phase 1)UnknownNCT04397926
What this trial is testing

Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Sun Yat-sen University 20
Not applicableNot Yet RecruitingNCT07758127
What this trial is testing

Updates and Insights on HER2 in Breast Cancer in Sohag Governorate

Who this might be right for
HER2 Status in Breast Cancer
Sohag University 100
Testing effectiveness (Phase 2)Ended earlyNCT00820924
What this trial is testing

Study of Lapatinib in Breast Cancer Patients With HER-2 Non-amplified Primary Tumors and HER-2 Positive or EGFR Positive Circulating Tumor Cells

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 23
Not applicableEnded earlyNCT00503841
What this trial is testing

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 44
Testing effectiveness (Phase 2)Study completedNCT03861156
What this trial is testing

D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer

Who this might be right for
Solid TumorNSCLCEGFR T790M
InventisBio Co., Ltd 290
Not applicableEnrolling By InvitationNCT07122882
What this trial is testing

Integrated Genomics in Oncogene-driven NSCLC With Acquired Resistance

Who this might be right for
Oncogene-addicted Non Small Cell Lung CancerEGFR MutationALK Fusion-positive Solid or CNS Tumors+10 more
Chang Gung Memorial Hospital 40
Testing effectiveness (Phase 2)UnknownNCT01861223
What this trial is testing

Afatinib Plus Nimotuzumb for NSCLC

Who this might be right for
NSCLC
Samsung Medical Center 50
Testing effectiveness (Phase 2)Ended earlyNCT00387894
What this trial is testing

Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Brain Tumors
Michael Prados 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT04743505
What this trial is testing

Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Metastatic Non Small Cell Lung Cancer
Washington University School of Medicine 27
Next Page